Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBIG administration route and vaccination timing to prevent HBV mother-to-child transmission
jRCTs031180137Recruiting
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of hepatitis B immune globulin in hepatitis B (HBV). Primary endpoint: Mother-to-child transmission prohibition rate. Started Mar 2012; status: recruiting.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on jRCTs031180137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180137.